The global pharmaceutical industry experienced a 14% drop in new job postings related to cloud in Q2 2024 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 16% decrease versus Q2 2023. GlobalData’s Pharma: Hiring Trends & Signals Q2 2024 report reveals comprehensive insights into hiring patterns, job roles, required skills, geographical trends, and key themes within the pharmaceuticals industry, facilitating anticipation of future workforce needs. Buy the report here.
Notably, Computer and Mathematical Occupations jobs accounted for a 36% share of the global pharmaceutical industry’s cloud-related total new job postings in Q2 2024, down 4% over the prior quarter.
Computer and Mathematical Occupations drive cloud-related hiring activity
Computer and Mathematical Occupations, with a share of 36%, emerged as the top cloud-related job roles within the pharmaceutical industry in Q2 2024, with new job postings drop by 4% quarter-on-quarter. Management Occupations came in second with a share of 17% in Q2 2024, with new job postings dropping by 23% over the previous quarter.
The other prominent cloud roles include Architecture and Engineering Occupations with a 4% share in Q2 2024, Life, Physical, and Social Science Occupations with a 3% share of new job postings.
Top five companies in pharmaceutical industry accounted for 35% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q2 2024 were Eurofins Scientific, AstraZeneca, Novartis, Merck, and ProPharma Group Holdings. Together they accounted for a combined share of 35% of all cloud-related new jobs in the pharmaceutical industry.
Eurofins Scientific posted 291 cloud-related new jobs in Q2 2024, AstraZeneca 276 jobs, Novartis 175 jobs, Merck 141 jobs, and ProPharma Group Holdings 138 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 38.58% share of total new job postings, Q2 2024
The largest share of cloud-related new job postings in the pharmaceutical industry in Q2 2024 was in the US with 38.58% followed by India (22.98%) and Spain (3.67%). The share represented by the US was two percentage points higher than the 36.73% share it accounted for in Q1 2024.
For further understanding of GlobalData's Pharma: Hiring Trends & Signals Q2 2024, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.